Translational Development Acquisition Corp Files Proxy Statement for Shareholder Meeting
AIRelated Layoffs May Not Guarantee Stock Gains Data Suggests
Klaviyo Expands Anthropic Partnership to Deploy Agentic Marketing Workflows on Claude
Tulsi Gabbard Resigns as Director of National Intelligence Marking Latest Cabinet Departure
Ferraris Strategic Bet Luce FiveSeat EV Targets Generational Technology Shift
Consumer Sentiment Plunges to Record Low in May as Iran Conflict Drives Gas Prices Higher
OTTR Q1 2026 Earnings Earnings Beat Estimates as EPS Surges 1986 Above Consensus
Marten Transport Q1 2026 Earnings Small EPS Beat Amidst Challenging Freight Environment
TriplePoint Venture Growth BDC Corp TPVG Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Resilient Portfolio
Live Ventures Q1 2026 Earnings Diversified Holding Company Reports Positive EPS Amid Market Challenges
CRDO Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge
VAL Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Offshore Drilling Market
Alphatec Holdings ATEC Slides 25 Key Levels to Watch Amid Market Pressure
Bluerock Acquisition Corp Unit BLRKU Holds Steady at 1002 Assessing the SPACs Current Support and Resistance Levels
GPAct III Acquisition Corp GPAT Holds Steady at 1080 as SPAC Awaiting Next Catalyst
Energy Vault Holdings NRGV Edges Higher Amid Renewed Interest in Energy Storage Solutions
BayCom Corp BCML Edges Higher Holding Above Key Support After Modest Advance
Icahn Enterprises IEP Holds Steady Near 755 as Trading Volume Remains Subdued
Nexstar Media Group NXST Edges Lower Amid Cautious Trading Support and Resistance Levels in Focus
Daxor Corporation DXR Holds Steady at 1082 as Shares Test Key Support Zone
Vince Holding Corp VNCE Edges Higher Amid Consolidation Near Support
SIMPPLE Ltd SPPL Edges Higher Amid Consolidation Near Key Resistance
SEC Updates IPO Regulatory Framework What Market Participants Should Know
PTN Q1 2026 Earnings EPS Beats Estimates by Wide Margin as Loss Narrows Stock Advances
Tarsus Pharmaceuticals TARS Shows Resilience Near Support After Moderate Decline